Post-Surgical Care with PolyPid – Life Sciences Today Podcast Episode 12

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ori Warshavsky, COO at PolyPid. With a platform that anchors drug delivery at the point of need, PolyPid has Phase 3 programs nearing FDA submission and a pipeline that could reshape how we think about infection control, post-op healing, and localized therapeutics. Ori joins us to talk about turning science into impact.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

• PolyPid was founded back in 2008, that’s a long arc in biotech. What’s new and wonderful today—and what’s different from when you started?
• You’ve got five programs in the pipeline and two already in Phase 3. You’re getting close to FDA submission—what are you focused on most at this stage?
• How does your anchored delivery system actually improve outcomes for patients, and where does it make the biggest difference?
• How do you plan to capture value commercially, especially in markets like hospital surgery or orthopedics, where adoption can be slow?
• What are the 3 things you’re most focused on achieving in the next 12–24 months—scientifically or operationally?
• If you could remove one major constraint right now, what would that unlock for PolyPid?

Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.

Be sure to subscribe to the Life Sciences Today on your favorite podcasting platform:

• Apple Podcasts
• Spotify
• iHeartRadio
• Amazon Music
• Pandora
• YouTube

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!